Cascadian Therapeutics Inc

FRA:3O61 (USA)  
(Delisted) € 8.01 (0%) Mar 14
At Loss
Market Cap:
€ 447.29M ($ 480.64M)
Enterprise V:
€ 447.29M ($ 480.64M)
Volume:
-
Avg Vol (2M):
-

Cascadian Therapeutics Inc Valuation Measures